CINECA IRIS Institutional Research Information System

FATTORE, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 554
SA - Sud America 255
NA - Nord America 245
EU - Europa 203
Continente sconosciuto - Info sul continente non disponibili 40
AF - Africa 19
Totale 1.316
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 211
BR - Brasile 202
VN - Vietnam 152
SG - Singapore 142
IT - Italia 103
CN - Cina 91
BD - Bangladesh 50
DE - Germania 41
KR - Corea 37
AR - Argentina 30
HK - Hong Kong 26
FR - Francia 23
ID - Indonesia 22
CA - Canada 14
MX - Messico 14
EC - Ecuador 11
IN - India 11
PL - Polonia 8
ZA - Sudafrica 7
IQ - Iraq 6
PY - Paraguay 5
ES - Italia 4
GB - Regno Unito 4
RU - Federazione Russa 4
TN - Tunisia 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CL - Cile 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
IE - Irlanda 2
JM - Giamaica 2
JP - Giappone 2
MA - Marocco 2
NL - Olanda 2
SY - Repubblica araba siriana 2
TR - Turchia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AT - Austria 1
BE - Belgio 1
BG - Bulgaria 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
FI - Finlandia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 1.276
Salva come PNG Salva come JPEG
Città #
Ho Chi Minh City 53
Ashburn 38
Frankfurt am Main 38
Seoul 37
Singapore 36
San Jose 29
Hanoi 27
Hong Kong 26
Beijing 21
New York 19
Milan 18
Mexico City 13
Rome 13
São Paulo 11
Haiphong 9
Guayaquil 8
Dallas 7
Los Angeles 7
Phoenix 7
Biên Hòa 6
Da Nang 6
Santa Clara 6
Brescia 5
Hải Dương 5
Porto Alegre 5
Sorocaba 5
Toronto 5
Warsaw 5
Duque de Caxias 4
Ha Long 4
Jakarta 4
Ninh Bình 4
Roubaix 4
São Bernardo do Campo 4
Belo Horizonte 3
Blumenau 3
Brasília 3
Bắc Giang 3
Catanduva 3
Chennai 3
Council Bluffs 3
Curitiba 3
Des Moines 3
Figino 3
Guarulhos 3
Joinville 3
Rio de Janeiro 3
Teresina 3
Thái Bình 3
Tunis 3
Wroclaw 3
Asunción 2
Atibaia 2
Boydton 2
Buffalo 2
Can Tho 2
Cape Town 2
Catalão 2
Chapecó 2
Chicago 2
Ciudad del Este 2
Corrientes 2
Decatur 2
Dubai 2
Dublin 2
Fortaleza 2
Genoa 2
Hortolândia 2
Johannesburg 2
João Pessoa 2
Lehigh Acres 2
Limburg an der Lahn 2
Madrid 2
Montreal 2
Mumbai 2
Newark 2
Osasco 2
Padua 2
Phủ Lý 2
Quito 2
Rosario 2
Salvador 2
San Antonio 2
Santa Maria 2
Surakarta 2
Suzano 2
São Leopoldo 2
Tashkent 2
Tirana 2
Tokyo 2
Turin 2
Venice 2
Verona 2
Addis Ababa 1
Al Qaţīf 1
Al Qāhirah al Jadīdah 1
Al'met'yevsk 1
Alausí 1
Albuquerque 1
Amsterdam 1
Totale 631
Salva come PNG Salva come JPEG
Nome #
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application 66
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance 64
Drug tolerance to target therapy in melanoma revealed at single cell level. What next? 56
ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma. Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin 53
Toxicity of aflatoxin B1 towards the vitamin D receptor (VDR) 48
C-Src recruitment is Involved in c-MET-mediated malignant behaviour of NT2D1 non-seminoma cells 43
Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies 39
CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions 38
Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients 38
The new world of RNA diagnostics and therapeutics 37
miR-579-3p controls melanoma progression and resistance to target therapy 37
MirRNAs for treatment and in vitro diagnosis of drug resistant tumors 37
Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma 37
Cancer stem cells and the slow cycling phenotype. how to cut the gordian knot driving resistance to therapy in melanoma 36
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma 35
ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors 34
In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma 34
Monoclonal antibody-induced ErbB3 receptor internalization and degradation inhibits growth and migration of human melanoma cells 33
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancer 33
microRNA-378a-5p iS a Novel Positive Regulator of Melanoma Progression 32
Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma 31
Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors 31
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma 30
Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization 30
Method for predicting the development of resistance to BRAF inhibiting drugs, alone or in combination with MEK inhibiting drugs, in an anti-tumour treatment 29
The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma 29
MicroRNAs in melanoma development and resistance to target therapy 28
Self-assembling nanoparticles for miRNA delivery towards precision medicine against melanoma 28
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and Application 27
miRNA-driven cancer cell plasticity, tolerance and therapy resistance: lessons from melanoma 26
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors 25
TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung 25
Role of WT1-ZNF224 interaction in the expression of apoptosis-regulating genes 24
Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma 22
The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma 21
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin 20
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma 19
Selective targeting of point-mutated KRAS through artificial microRNAs 19
Development of an innovative duplex digital PCR assay for circulating MiRNA ratio quantification in metastatic melanoma 18
PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models 4
Totale 1.316
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.096
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202541 0 0 0 0 0 0 0 0 0 0 0 41
2025/20261.106 89 24 187 270 104 51 17 71 92 105 58 38
2026/2027169 10 120 39 0 0 0 0 0 0 0 0 0
Totale 1.316